NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 38.360
- +1.280+3.45%
Close Feb 25 16:00 ET
- 38.000
- -0.360-0.94%
Pre 05:57 ET
78.27BMarket Cap24.34P/E (TTM)
38.400High37.560Low10.54MVolume37.560Open37.080Pre Close400.46MTurnover0.53%Turnover Ratio24.34P/E (Static)2.04BShares44.37652wk High4.52P/B75.63BFloat Cap31.37152wk Low1.52Dividend TTM1.97BShs Float44.376Historical High3.97%Div YieldTTM2.27%Amplitude6.306Historical Low38.007Avg Price1Lot Size
GlaxoSmithKline News
Top Gap Ups and Downs on Tuesday: LI, PHG, MSTR and More
UK's FTSE 100 Starts New Week Flat; GSK Gains
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
Peering Into GSK's Recent Short Interest
GSK Closes Up to $1 Billion Purchase of US-based IDRx
GSK Completes Acquisition of IDRx
GSK PLC GSK Completes Acquisition of IDRx, Inc.
GSK PLC Starts Buyback Program
GSK Plc Commences Share Buyback Programme
GSK Plc (GSK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
Trump Tells Big Pharma to Bring Production Home or Face Tariffs: Bloomberg News
GlaxoSmithKline (GSK.US) has submitted a new drug for COPD for market approval in China.
GlaxoSmithKline (GSK.US) announced that the National Medical Products Administration has accepted the new drug application for IL-5 monoclonal antibody Nucala (mepolizumab).
GSK Announces Dr Gavin Screaton to Join the Board as Non-Executive Director
First Meeting of CDC Vaccine Advisory Panel Under RFK Jr. Postponed
European Equities Traded in the US as American Depositary Receipts Edge Higher in Thursday Trading
GSK to Sell 500K Doses of Bird Flu Vaccines to Canada
GlaxoSmithKline (GSK) Gets a Buy From Bernstein
GSK's Lung Disease Treatment Application Accepted for Review by Chinese Regulator
GlaxoSmithKline To Go Ex-Dividend On February 21st, 2025 With 0.40065 USD Dividend Per Share
GSK's Penmenvy Vaccine for Meningococcal Disease Gets US FDA Approval